Clinical Trial

Effects of Blue-enriched White Light Therapy in Patients with Fibromyalgia

Enrolling by Invitation

Record status

This record was last updated February 24, 2025 (before its estimated October 31, 2025 completion). Its status may not reflect the trial's current state.

Summary

Fibromyalgia is a chronic condition with an unclear etiology. The syndrome includes symptoms such as chronic musculoskeletal pain, cognitive dysfunctions, fatigue, sleep disorders, and circadian rhythm disturbances. Fibromyalgia-related pain is associated with a substantial socioeconomic burden including greater health care costs and productivity loss from work. Light therapy can improve sleep quality and sleep architecture, advance sleep phases and reduce pain sensitivity and that the effect of light therapy on mood and cognitive function have been widely supported.This randomized controlled study aims to examine the effects of light therapy on sleep quality, depressive symptoms, psychomotor vigilance performance, and overall symptom severity in patients with fibromyalgia.

Protocol Amendment History 8 amendments

This ClinicalTrials.gov record has been amended 8 times since 2020-08-06; most recent amendment 2025-02-20.

Status change: Not Yet Recruiting → Enrolling by Invitation 2021-04-06

Trial Details

NCT Number	NCT04504721
Lead Sponsor	Taipei Medical University Collaborators: Ministry of Science and Technology, Taiwan
Conditions	Fibromyalgia
Enrollment	80 participants
Start Date	2020-05-22
Primary Completion	2025-10-31 (estimated)
Study Completion	2025-10-31 (estimated)
Updated on ClinicalTrials.gov	2025-02-24